Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04786106
PHASE4

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Sponsor: Charitable Union for the Research and Education of Peyronie's Disease

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

Official title: Comparison of Collagenase Clostridium Histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2020-12-30

Completion Date

2027-02-15

Last Updated

2025-02-13

Healthy Volunteers

Yes

Interventions

DRUG

Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex] (CCH)

Men in this cohort would receive the full series of 8 Xiaflex injections: 2 injections separated by 1-3 days, repeated 3 additional times with 6 week breaks between treatments.

PROCEDURE

Penile Plication Surgery

Men in this cohort would undergo surgery using either penile plication or incision and grafting. The specific surgery would be selected based on commonly used criteria: plication for curvatures \<70 degrees; I\&G used for ≥70 degrees or severe hourglass / hinge deformities. However, the specific surgery (plication vs I\&G) will ultimately be decided based on the primary investigator's clinical judgment.

PROCEDURE

Incision and Grafting (I&G) Surgery

Men in this cohort would undergo surgery using either penile plication or incision and grafting. The specific surgery would be selected based on commonly used criteria: plication for curvatures \<70 degrees; I\&G used for ≥70 degrees or severe hourglass / hinge deformities. However, the specific surgery (plication vs I\&G) will ultimately be decided based on the primary investigator's clinical judgment.

DEVICE

RestoreX Penile Traction Device

RestoreX is a Class I PTT device developed by PathRight Medical, is registered with the FDA, and has randomized controlled data demonstrating efficacy when used for the treatment of PD.

Locations (1)

The Male Fertility and Peyronie's Clinic

Orem, Utah, United States